Skip to main content
Syros Pharmaceuticals, Inc. (SYRS)
OTCMKTS · Delayed Price · Currency is USD
0.0302
+0.0002 (0.67%)
May 9, 2025, 2:02 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Gene Control Medicines
9.94M
Log In
Log In
Log In
Log In
Gene Control Medicines Growth
-33.23%
Log In
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
United States
9.94M
Log In
Log In
Log In
Log In
United States Growth
-33.23%
Log In
Log In
Log In
Log In